Table 3.
BPI Assessment
| Control Group (n=60) | Esketamine Group (n=60) | P value | |
|---|---|---|---|
| Most intense pain in 24 hours, median (IQR) | 2 (2–3) | 2 (2–3) | 0.084 |
| Minimal pain at 24 hours, median (IQR) | 1 (0–1) | 0 (0–1) | 0.147 |
| Mean pain level over 24 hours, median (IQR) | 1 (1–1) | 1 (1–1) | 0.275 |
| Current pain level, median (IQR) | 1 (1–1) | 1 (1–1) | 0.316 |
| Degree to which pain affects daily life, median (IQR) | 0 (0–0.75) | 0 (0–1.5) | 0.978 |
| Degree to which pain affects mood, median (IQR) | 0 (0–0) | 0 (0–0) | 0.083 |
| Degree to which pain affects walking ability, median (IQR) | 0 (0–0) | 0 (0–0) | 0.234 |
| Degree to which pain affects daily tasks, median (IQR) | 0 (0–0) | 0 (0–0) | 0.411 |
| Degree to which pain affects relationships with others, median (IQR) | 0 (0–0) | 0 (0–0) | 0.175 |
| Degree to which pain affects sleep, median (IQR) | 0 (0–2) | 0 (0–2.75) | 0.485 |
| Degree to which pain affects interest in life, median (IQR) | 0 (0–0) | 0 (0–0) | 0.139 |